• Tute Genomics Announces Investment Round from Intermountain, Tencent

    Jun 16, 2015, 15:00 PM by Michael Croft
    Bio-IT World News Brief | Tute Genomics today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including Intermountain Healthcare, Healthbox, and China-based Tencent.
    Full story
  • Whole Genome Assembly with Nanopore Data

    Jun 16, 2015, 08:50 AM by Michael Croft
    Bio-IT World News Brief Nature Methods has published a paper by researchers at the University of Birmingham and University of Toronto, demonstrating a complete de novo assembly of an E. coli genome using only data from an Oxford Nanopore MinION Sequencer.
    Full story
  • Matthew Trunnell Joins Fred Hutchinson Cancer Research Center

    Jun 16, 2015, 00:00 AM by Michael Croft
    Xconomy | Trunnell leaves the Broad to serve as the chief information officer as the biomedical institution moves into an era of deep genomic sequencing.
    Full story
  • FDA taps PatientsLikeMe to test the waters of social media adverse event reporting

    Jun 16, 2015, 00:00 AM by Michael Croft
    mobihealthnews | PatientsLikeMe has announced a research partnership with the FDA: The agency will assess the platform's feasibility as a way to generate adverse event reports, which the FDA uses to regulate drugs after their release into the market.
    Full story
  • Agena Bioscience European Distributors Expand to KAWA.SKA and BioGen-Analytica

    Jun 11, 2015, 00:00 AM by Michael Croft
    SAN DIEGO, CA, UNITED STATES - Jun 11, 2015 - Agena Bioscience today expanded its European distributors through new relationships with KAWA.SKA in Poland and BioGen-Analytica in Russia
    Full story
  • Outpouring of Commentary on CRISPR Germline Editing

    Jun 10, 2015, 13:30 PM by Michael Croft
    Bio-IT World News Brief | A supplementary document to a recent Nature Biotechnology article on the use of CRISPR-Cas9 genome editing in the human germline offers complete Q&A's with over 20 experts in the field, taking on pressing questions about how and whether this technology can be regulated.
    Full story
  • ClinGen and Lessons for the Precision Medicine Initiative

    Jun 10, 2015, 10:00 AM by Michael Croft
    Bio-IT World | Heidi Rehm has been involved in ClinGen since its inception and recently published a report on the project in the New England Journal of Medicine. Rehm’s experience with ClinGen will make hers an important voice as the infrastructure needs for a Precision Medicine Initiative are better defined.
    Full story
  • DIGITAL SCIENCE ANNOUNCES NEW MANAGING DIRECTOR

    Jun 9, 2015, 00:00 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jun 9, 2015 - London, UK & Boston, USA. June 9th 2015:  Digital Science announced today the appointment of Daniel Hook, currently Director of Research Metrics at Digital Science, as its new Managing Director
    Full story
  • BGI's Industrial Scale Sequencer Challenges Illumina's HiSeq Line

    Jun 8, 2015, 17:00 PM by Michael Croft
    Bio-IT World | BGI, the Shenzhen-based global genomics corporation, has revealed its first DNA sequencing instrument for worldwide markets, Revolocity: an ultra-high-throughput, fully automated system based on technology developed by BGI's subsidiary Complete Genomics.
    Full story
  • Kickstarter Launched for Social Reader

    Jun 8, 2015, 16:00 PM by Michael Croft
    Bio-IT World | David Mittelman and his colleagues at N of Everyone today launch a Kickstarter campaign to fund Reader, a mobile and social reading platform to promote conversation and collaboration within science. 
    Full story
  • A New Regenerative Drug Molecule For Pancreas Was Introduced

    Jun 8, 2015, 00:00 AM by Michael Croft
    NEW YORK, NY - Jun 8, 2015 - BOC Sciences-recently a new synthetic molecule was introduced by an authoritative research center in America
    Full story
  • The Human Virome's Permanent Mark

    Jun 5, 2015, 13:50 PM by Michael Croft
    Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
    Full story
  • Rho Chairman and Co-Founder Ronald W. Helms Inducted as a Fellow Of the Society for Clinical Trials

    Jun 5, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Jun 5, 2015 - For Immediate Release Rho Chairman and Co-Founder Ronald W. Helms Inducted as a FellowOf the Society for Clinical Trials Chapel Hill, NC  ̶  June 4, 2015  ̶  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that its Chairman and Co-founder Ronald W
    Full story
  • Vicon Celebrates Accelerated Growth in Life Sciences with the Addition of New Customers

    Jun 5, 2015, 00:00 AM by Michael Croft
    OXFORD, UNITED KINGDOM - Jun 5, 2015 - Motion capture technology specialist Vicon has announced growing momentum in the life sciences sector with several recent customer wins
    Full story
  • Celgene Bluebird Streamline CAR-T Partnership To Fight Myeloma

    Jun 4, 2015, 00:00 AM by Michael Croft
    Xconomy | The immuno-oncology field is moving fast these days, but the tough-to-treat blood cancer multiple myeloma has not been one of its early targets.
    Full story
  • Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation

    Jun 4, 2015, 00:00 AM by Michael Croft
    ALBANY, UNITED STATES - Jun 4, 2015 - Market Research Reports Search Engine (MRRSE) has announced the addition of the ' Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation' report by Market Research Reports Search Engine to its rapidly growing market research report database
    Full story
  • Business The billion-dollar biotech

    Jun 4, 2015, 00:00 AM by Michael Croft
    Nature News & Comment | Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.
    Full story
  • Genomics England Names Four Finalist Companies to Begin Interpretation

    Jun 3, 2015, 13:00 PM by Michael Croft
    Bio-IT World News Brief | Genomics England today announced four finalist companies and one alternate that will begin working on the interpretation of the genomes of the first 8,000 patients participating in the 100,000 Genomes Project.  Congenica and Omicia will work in rare diseases, Nanthealth in cancer, and Wuxi Nextcode in both rare disease and cancer for this stage of the project. Lockheed Martin in partnership with Cypher Genomics is the alternate.
    Full story
  • Thomson Reuters Honors Top BioPharma Deals

    Jun 3, 2015, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jun 3, 2015 - The Intellectual Property and Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, recently honored Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year
    Full story
  • BaseHealth Opens Its Genomic Health Engine to Outside Developers

    Jun 2, 2015, 15:00 PM by Michael Croft
    Bio-IT World | BaseHealth, an Illumina-associated company using genomic data to provide patients with personalized health recommendations, is shifting to a more behind-the-scenes model, releasing an open API to integrate its own analysis engine into third-party apps and health platforms.
    Full story